StockWatch
·
Biotechnology: Pharmaceutical Preparations
RegulatoryApr 28, 2026, 04:22 PM

IFRX Regains Nasdaq Minimum Bid Price Compliance

AI Summary

InflaRx N.V. announced it has regained compliance with The Nasdaq Stock Market LLC's minimum bid price requirement. The company was previously notified on March 11, 2026, that its ordinary shares were trading below $1.00 for 30 consecutive business days. Nasdaq confirmed on April 27, 2026, that InflaRx's closing bid price was $1.00 or greater for 10 consecutive business days, from April 13 to April 24, 2026, thereby closing the matter.

Key Highlights

  • InflaRx N.V. was notified on March 11, 2026, of non-compliance with Nasdaq's $1.00 minimum bid price rule (5450(a)(1)).
  • The company was given an initial compliance period of 180 calendar days, until September 7, 2026.
  • On April 27, 2026, Nasdaq confirmed the closing bid price was $1.00 or greater for 10 consecutive business days.
  • The compliance period ran from April 13, 2026, to April 24, 2026.
  • InflaRx N.V. has successfully regained compliance with Nasdaq Listing Rule 5450(a)(1).